Copyright
©The Author(s) 2025.
World J Clin Pediatr. Sep 9, 2025; 14(3): 103788
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.103788
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.103788
Table 3 Comparison between casein A1–induced intolerance and cow milk protein allergy
Aspect | Casein A1–induced intolerance | CMPA |
Mechanism | Non-immune-mediated; caused by the release of BCM-7 during digestion of A1 β-casein | Immune-mediated response to milk proteins (e.g., casein, whey) via IgE or T-cell pathways |
Primary trigger | A1 β-casein found in milk from breeds like Holstein and Friesian cows | Any cow’s milk protein, including casein and whey |
Symptoms | Gastrointestinal symptoms: Constipation, bloating, abdominal pain. No systemic manifestations | Wide range: Gastrointestinal (vomiting, diarrhea), skin (eczema, rash), respiratory (wheezing), or systemic reactions (anaphylaxis) |
Onset | Dose-dependent; occurs after consuming significant amounts of A1 β-casein | It can occur after small amounts of milk protein; onset may be immediate (IgE-mediated) or delayed (non-IgE-mediated) |
Age of onset | It is more common in older infants and children and rare in newborns | Typically manifests in infancy, often within the first year of life |
Diagnosis | Clinical observation with symptom resolution following a switch to A2 milk. No specific diagnostic tests were available | Based on clinical history, specific IgE tests, skin prick tests, and elimination diets with oral food challenges |
Management | Substituting with A2 milk, there is no need for hypoallergenic formulas unless other sensitivities coexist | Avoid all cow’s milk proteins; use extensively hydrolyzed or amino acid-based formulas for infants |
Systemic involvement | Absent; symptoms are limited to the gastrointestinal system | Possible, particularly in IgE-mediated cases (e.g., respiratory or skin involvement) |
Prognosis | Symptoms resolve with dietary modification, such as switching to A2 milk | Many children outgrow CMPA by 3-5 years; strict dietary management is required until the resolution is reached |
Nutritional impact | Minimal if A2 milk or suitable dietary alternatives are included | Risk of nutritional deficiencies if dietary restrictions are not appropriately managed |
- Citation: Al-Beltagi M, Saeed NK, Bediwy AS, Bediwy HA, Elbeltagi R. Cow milk protein allergy mimics in infancy. World J Clin Pediatr 2025; 14(3): 103788
- URL: https://www.wjgnet.com/2219-2808/full/v14/i3/103788.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i3.103788